DSS Inc Q3 2025 Earnings Narrower Loss Beats Expectations CTO Q1 2026 Earnings Massive EPS Beat as Earnings Surge Past Estimates Ionis Pharmaceuticals Q1 2026 Earnings EPS Beat Driven by Cost Discipline Stock Holds Steady ATNI Q1 2026 Earnings Significant EPS Miss Amid Challenging Quarter Kazia Therapeutics Q1 2026 Earnings A WiderThanExpected Loss Yet Shares Gain Ground UNM Q1 2026 Earnings EPS Slightly Above Estimates Amid Stable Operations